Causes of Hemorrhagic Cystitis
Hemorrhagic cystitis is primarily caused by radiation therapy, chemotherapeutic agents (particularly cyclophosphamide), viral infections, and bacterial infections, with radiation and cyclophosphamide being the most common etiologies. 1, 2, 3
Major Etiologies
1. Treatment-Related Causes
Chemotherapy:
Radiation Therapy:
2. Infectious Causes
Viral:
- BK virus, adenovirus, CMV (particularly in immunocompromised hosts)
- More common in transplant recipients and immunosuppressed patients 2
Bacterial:
3. Other Causes
Trauma:
- Bladder instrumentation or catheterization
- Recent urologic procedures 1
Systemic Diseases:
- Autoimmune conditions
- Coagulopathies or bleeding disorders 3
Idiopathic:
- No identifiable cause despite thorough evaluation 3
Risk Factors
For Radiation-Induced Hemorrhagic Cystitis:
- History of abdominal surgery
- Pelvic inflammatory disease
- Hypertension
- Diabetes mellitus
- Smoking
- Older age
- Obesity/overweight 1
For Chemotherapy-Induced Hemorrhagic Cystitis:
- High doses of cyclophosphamide
- Inadequate hydration during treatment
- Pre-existing bladder conditions
- Urinary tract obstructions 4
Clinical Presentation and Diagnosis
Presentation ranges from microscopic hematuria to gross hematuria with clots and urinary retention. Associated symptoms may include:
- Dysuria
- Urinary frequency
- Nocturia
- Hesitancy
- Suprapubic pain 1
Diagnostic workup should include:
- Urinalysis with microscopy (≥3 RBCs per HPF confirms hematuria) 1
- Urine culture to rule out infection
- Imaging studies (ultrasound, CT urography, or MRI) to evaluate upper and lower urinary tract 1
- Cystoscopy to directly visualize bladder mucosa 1
Prevention and Management
Prevention:
For cyclophosphamide therapy:
- Aggressive hydration with forced diuresis
- Frequent bladder emptying
- Mesna administration to prevent bladder toxicity 4
For radiation therapy:
- IMRT techniques to reduce bladder exposure
- Maintaining bladder dose D2cm³ ≤80 Gy EQD2 1
Treatment:
- Conservative management for mild cases
- Hydration and clot evacuation for moderate cases
- For severe cases:
Hemorrhagic cystitis represents a significant clinical challenge with substantial morbidity and potential mortality. Early recognition of risk factors and prompt implementation of preventive measures are essential to reduce its incidence and severity.